X11α impairs γ- but not β-cleavage of amyloid precursor protein
Journal of Neurochemistry, ISSN: 0022-3042, Vol: 88, Issue: 4, Page: 971-982
2004
- 32Citations
- 26Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations32
- Citation Indexes32
- CrossRef32
- 32
- Captures26
- Readers26
- 16
Article Description
The phosphotyrosine binding domain of the neuronal protein X11α/mint-1 binds to the C-terminus of amyloid precursor protein (APP) and inhibits catabolism to β-amyloid (Aβ), but the mechanism of this effect is unclear. Coexpression of X11α or its PTB domain with APPswe inhibited secretion of Aβ40 but not APPsβswe, suggesting inhibition of γ- but not β-secretase. To further probe cleavage(s) inhibited by X11α, we coexpressed γ-secretase (BACE-1) or a component of the γ-secretase complex (PS-1Δ9) with APP, APPswe, or C99, with and without X11α, in HEK293 cells. X11α suppressed the PS-1Δ9-induced increase in Aβ42 secretion generated from APPswe or C99. However, X11α did not impair BACE-1-mediated proteolysis of APP or APPswe to C99. In contrast to impaired γ-cleavage of APPswe, X11α or its PTB domain did not inhibit γ-cleavage of NotchΔE to NICD (the Notch intracellular domain). The X11α PDZ-PS.1Δ9 interaction did not affect γ-cleavage activity. In a cell-free system, X11α did not inhibit the catabolism of APP C-terminal fragments. These data suggest that X11α may inhibit Aβ secretion from APP by impairing its trafficking to sites of active γ-secretase complexes. By specifically targeting substrate instead of enzyme X11α may function as a relatively specific γ-secretase inhibitor.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0346435147&origin=inward; http://dx.doi.org/10.1046/j.1471-4159.2003.02234.x; http://www.ncbi.nlm.nih.gov/pubmed/14756819; https://onlinelibrary.wiley.com/doi/10.1046/j.1471-4159.2003.02234.x; https://dx.doi.org/10.1046/j.1471-4159.2003.02234.x; https://onlinelibrary.wiley.com/doi/full/10.1046/j.1471-4159.2003.02234.x
Wiley
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know